NT

Naveen Tyagi

Active Director Director DIN 06861283
DIN 06861283 First appointment Jul 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2014
Shareholding value •••• Premium profile

About Naveen Tyagi

Data last updated:

Naveen Tyagi is a Director at Gts Mediquest Private Limited (since 2014). The company operates in Healthcare. Gts Mediquest Private Limited reported revenue of ₹8.59 Cr (FY 2025).

DIN 06861283
Primary Designation Director
Industry Healthcare
First Appointment 01 Jul 2014
Oldest Company Age 12 yrs
Largest company Gts Mediquest Private Limited · ₹8.59 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gts Mediquest Private Limited U85100DL2014PTC268482
Director01 Jul 20142014₹8.59 Cr (FY 2025)Active

Board colleagues of Naveen Tyagi

Directorship timeline

Open interactive timeline →
Gts Mediquest Private Limited
Premium access

Shareholding and investment profile for Naveen Tyagi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveen Tyagi

Naveen Tyagi currently holds 1 directorship: Gts Mediquest Private Limited (Director, since 01 Jul 2014, revenue ₹8.59 Cr (FY 2025)).

Naveen Tyagi was first appointed on 01 Jul 2014 as Director at Gts Mediquest Private Limited.

The current boards of Naveen Tyagi's companies include Harish Sharma (Gts Mediquest Private Limited), Kalpna Tyagi (Gts Mediquest Private Limited), Neetu Rani (Gts Mediquest Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available